期刊文献+

国际间合作遏制青光眼:2008年3月6日第一届“世界青光眼日” 被引量:5

原文传递
导出
摘要 众所周知,青光眼是全球第二位可治疗的致盲性眼病。作为不可逆盲的重要原因,其防治已成为重要的公共卫生问题,其在世界各国致盲眼病的排名不断攀升。尽管在发展中国家及发达国家,白内障和年龄相关性黄斑变性分别是首位的致盲原因,
出处 《眼科》 CAS 2008年第1期10-11,共2页 Ophthalmology in China
  • 相关文献

参考文献7

  • 1Quigley HA,Broman AT.The number of people with glaucoma worldwide in 2010 and 2020.Br J Ophthalmol,2006,90:262-267.
  • 2Sommer A,Tielsch JM,Katz J,et al.Relationship between intraocular pressure and primary open-angle gluacoma among white and black Americans.Arch Ophthalmol,1991,109:1090-1095.
  • 3Feiner L,Pihz-Seymour J.Collaborative initial glaucoma treatment study:a summary of results to date.Curr Opin Ophthalmol,2003,14:106-111.
  • 4Heijl A,Leske MC,Bengtsson B,et al.Reduction of intraocular pressure and glaucoma progression:results from the Early Manifest Glaucoma Trial.Arch Ophthalmol,2002,120:1268-1279.
  • 5AGIS Investigators.7.The relationship between control of intraocular pressure and visual field deterioration.Am J Ophthalmol,2000,130:429-440.
  • 6Kass MA,Heuer DK,Higginbotham E J,et al.The Ocular Hypertension Treatment Study.A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.Arch Ophthalmol,2002,120:701-713.
  • 7Olthoff CM,Schouten JS,van de Borne BW,et al.Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension:an evidence-based review.Ophthalmology,2005,112:953-961.

同被引文献52

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部